Atul Gawande’s announcement last week that he was stepping down as CEO of a high-profile health venture created by the leaders of Amazon, JPMorgan Chase, and Berkshire Hathaway, came after a frustrating two years marked by high turnover in key positions, potential duplication with the work of one of its founding companies, and halting progress toward its goals, a STAT examination has found.
COVID-19:
News
Two years of halting progress and high turnover preceded Atul Gawande's exit as Haven CEO
By Stat News
| May 20, 2020
Most Popular
#1
Study Shows COVID-19 Body Count 20 Times Higher Than Seasonal Flu Deaths
Confusion about lethality comparisons may be owing to "a knowledge gap" in how the CDC reports on seasonal influenza and COVID-19. ...
Read More #2
Study Puts U.S. COVID-19 Infection Fatality Rate at 1.3%
As alarming as the numbers appear, the researchers said, their estimates "may be slightly conservative." ...
Read More #3
Fact check: Hospitals get paid more if patients listed as COVID-19, on ventilators
Sen. Scott Jensen, R-Minn., a physician in Minnesota, was interviewed by "The Ingraham Angle" host Laura Ingraham on April 8 on Fox News and claimed hospitals get paid more if Medicare patients are...
Read More #4
Coronavirus becomes number one cause of death per day in U.S., surpassing heart disease and cancer
COVID-19, the illness caused by the novel coronavirus, is now the deadliest disease in the United States, killing more people per day than cancer or heart disease. According to a graph published...
Read More #5
4 Ethical Dilemmas for Healthcare Organizations During the COVID-19 Pandemic
There has already been rationing of testing in the United States and rationing of critical care resources is likely if severely ill COVID-19 patients surge significantly. ...
Read More